doi:10.1007/s12325-022-02153-x Yao H, Zhang A, Li D, et al
The Need for New Real-World Evidence The sharp increase in perinatal GLP-1 RA use underscores the urgent demand for comprehensive, evidence-based safety data
If Im looking at the map here at the bottom left corner the United States
Comprehensive Monitoring: Regular blood tests and health assessments would be critical to monitor metabolic markers, hormone levels, and general well-being
Other applications include using it as a fluid replenisher, in inhalation medications, and in some ophthalmic (eye health) products
The primary objective of the study was to demonstrate that orforglipron is superior to placebo in mean body weight change from baseline at 72 weeks.